Lantheus Holdings, Inc (LNTH) Stock Price
LNTHStock
$99.70+76.90%52W
Market Cap$6.51B
P/E27.87x
PEG Ratio0.58
Div yield—
Beta0.05
LNTH Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)10.59%
Price vs S&P 500 (4W)0.75%
PEG Ratio0.58
VGM Score64.65
P/E Ratio (Annual)27.87x
LNTH Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.30 | $1.55 | +18.90%(+$0.25) | |
| Q1 2026 | $1.23 | $1.46 | +18.78%(+$0.23) | |
| Q4 2025 | $1.17 | $1.67 | +42.92%(+$0.50) | |
| Q3 2025 | $1.27 | $1.27 | +0.24%(+$0.00) | |
| Q2 2025 | $1.68 | $1.57 | -6.29%(-$0.11) |
LNTH Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.11
4.11
4.05
3.59
Industry Peers — In Vitro Diagnostics(18)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|---|---|---|
LNTHLantheus Holdings, Inc | C | B | B | 4.2x | 2.4% | 61.0% | 40.7% | $99.70 |
| IDXXIdexx Laboratories Inc | D | B | B | 9.7x | 12.8% | 62.5% | 14.3% | $560.36 |
| NEOGNeogen Corp | C | C | A | 2.9x | -0.3% | 47.4% | — | $11.81 |
| CLDXCelldex Therapeutics, Inc | F | F | C | 13683.0x | -97.3% | 17.6% | — | $27.53 |
| NTLAIntellia Therapeutics, Inc | D | D | C | 26.9x | 12.6% | — | — | $11.42 |
| QDELQuidelOrtho Corporation Common Stock | C | C | C | 0.3x | -2.5% | 44.6% | — | $12.91 |
| ACHVAchieve Life Sciences, Inc. | F | F | B | 36.8x | -89.3% | — | — | $6.38 |
| MYGNMyriad Genetics Inc | C | C | D | 0.5x | -3.2% | 68.8% | — | $3.98 |
| TKNOAlpha Teknova, Inc. Common Stock | D | C | B | 8.7x | 12.3% | 34.6% | — | $7.08 |
| NNNNAnbio Biotechnology Class A Ordinary Shares | F | C | F | 34.0x | -5.7% | 89.0% | — | $3.13 |
| IMDXInsight Molecular Diagnostics Inc. Common Stock | F | D | C | 59.0x | -60.8% | 48.3% | — | $3.01 |
About Lantheus Holdings, Inc
Lantheus Holdings is a radiopharmaceutical company that develops and markets imaging agents and diagnostic solutions focused on oncology and precision diagnostics. Its products are used by physicians and technologists in clinical settings to identify and monitor disease. The company operates primarily in the United States, with international distribution networks in Europe, Canada, Australia, Asia-Pacific, and Latin America.